Advertisement
mudit kapoor

Mudit Kapoor

Adar Poonawalla poses with first consignment of Covishield (Photo credit: Twitter)

How profitable is Adar Poonawalla's Serum Institute?

by Manoj Sharma |May 13, 2021

At Rs 300, the expected earnings from, let's say, 500 million doses of Covishield stand at about Rs 15,000 crore, which is near three times the total revenue of Serum Institute in FY20

Covid-19 vaccination: India vs the world

by Mudit Kapoor |May 11, 2021

India is trailing other countries in the percentage of population that has been vaccinated against Covid-19

Global marketcap shoots up, despite COVID-19

by Mudit Kapoor |May 7, 2021

During the past 12 months of the coronavirus pandemic, market capitalisation of major stock exchanges in the world increased by 49.5% ($37.4 trillion).

India markets lag in April 21

by Mudit Kapoor |May 6, 2021

In April 2021, key global stock markets such as Taiwan, US, UK, Korea and Brazil closed higher while Japan, India and Russia ended lower.'

5 million COVID cases in just 15 days!

by Mudit Kapoor |May 4, 2021

Amidst the devastating second wave of the pandemic, India took just 15 days to add 5 million cases (15 million to 20 million) to its COVID tally

Unemployment rate highest since Dec 2020

by Mudit Kapoor |May 3, 2021

Joblessness has risen to 8% in April 2021 amid the second wave of pandemic from 6.5% in March 2021

GST revenue sets new record

by Mudit Kapoor |May 3, 2021

Goods and services tax collections have reached Rs 1.41 lakh crore in April 2021

At current rate, India's COVID-19 vaccination to take 2 years & 9 months

by Mudit Kapoor |May 2, 2021

Vaccinating 70% of all Indians-the herd immunity threshold-will take 2 years & 9 months

Low base effect propels eight core industries

by Mudit Kapoor |Apr 30, 2021

After falling 3.8% in February, India's eight core industries have grown by 6.8% year-on-year in March 2021 due to low base effect.

Cloud over India's double-digit GDP growth in FY22

by Mudit Kapoor |Apr 27, 2021

As the second wave of COVID-19 engulfs India, resulting in more lockdowns and curtailed economic activity, agencies have revised downwards India's FY22 GDP forecast by up to 2 per cent.